ArticlemedRxiv : the preprint server for health sciences2026

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

Byram H Ozer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.